Concepts (109)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
Multiple Pulmonary Nodules | 2 | 2019 | 115 | 1.33 | Why? |
Lung Neoplasms | 5 | 2021 | 3228 | 0.77 | Why? |
Phantoms, Imaging | 1 | 2019 | 146 | 0.75 | Why? |
Radiographic Image Interpretation, Computer-Assisted | 5 | 2020 | 869 | 0.71 | Why? |
Solitary Pulmonary Nodule | 1 | 2018 | 83 | 0.66 | Why? |
Pericardium | 1 | 2019 | 228 | 0.63 | Why? |
Preventive Health Services | 1 | 2021 | 501 | 0.58 | Why? |
Tomography, X-Ray Computed | 13 | 2021 | 25144 | 0.53 | Why? |
Early Detection of Cancer | 3 | 2021 | 1956 | 0.53 | Why? |
Adipose Tissue | 1 | 2019 | 612 | 0.51 | Why? |
Scleroderma, Systemic | 1 | 2019 | 583 | 0.48 | Why? |
Computed Tomography Angiography | 2 | 2019 | 2153 | 0.45 | Why? |
Lung Diseases, Interstitial | 2 | 2019 | 1476 | 0.44 | Why? |
Radiation Dosage | 2 | 2019 | 585 | 0.27 | Why? |
Lung | 9 | 2021 | 31049 | 0.26 | Why? |
Radiographic Image Enhancement | 1 | 2019 | 89 | 0.19 | Why? |
Radionuclide Imaging | 1 | 2019 | 184 | 0.17 | Why? |
Pulmonary Emphysema | 1 | 2019 | 122 | 0.17 | Why? |
Disease Transmission, Infectious | 1 | 2021 | 9044 | 0.17 | Why? |
Hypercholesterolemia | 1 | 2019 | 175 | 0.16 | Why? |
Pleural Diseases | 1 | 2017 | 68 | 0.16 | Why? |
Tumor Burden | 1 | 2018 | 369 | 0.16 | Why? |
Incidental Findings | 1 | 2021 | 487 | 0.16 | Why? |
Pneumonectomy | 1 | 2019 | 278 | 0.15 | Why? |
Radiography | 2 | 2021 | 1576 | 0.15 | Why? |
Ultrasonography | 2 | 2020 | 4409 | 0.13 | Why? |
Feasibility Studies | 2 | 2021 | 3467 | 0.13 | Why? |
Lower Extremity | 1 | 2018 | 593 | 0.12 | Why? |
Program Evaluation | 1 | 2021 | 1929 | 0.12 | Why? |
Peripheral Arterial Disease | 1 | 2018 | 471 | 0.12 | Why? |
Contrast Media | 1 | 2018 | 1011 | 0.11 | Why? |
Organizational Innovation | 1 | 2021 | 2468 | 0.11 | Why? |
Early Diagnosis | 1 | 2019 | 2443 | 0.10 | Why? |
Radiography, Thoracic | 3 | 2021 | 5486 | 0.10 | Why? |
Image Processing, Computer-Assisted | 1 | 2018 | 1383 | 0.09 | Why? |
Italy | 7 | 2021 | 38444 | 0.09 | Why? |
Reproducibility of Results | 3 | 2020 | 11304 | 0.09 | Why? |
Algorithms | 3 | 2020 | 7346 | 0.09 | Why? |
Observer Variation | 2 | 2021 | 622 | 0.08 | Why? |
Aged | 12 | 2021 | 215776 | 0.08 | Why? |
Lopinavir | 1 | 2020 | 4308 | 0.08 | Why? |
Body Mass Index | 1 | 2019 | 4306 | 0.07 | Why? |
Ritonavir | 1 | 2020 | 4212 | 0.07 | Why? |
Middle Aged | 12 | 2021 | 270681 | 0.07 | Why? |
Diagnosis, Differential | 1 | 2019 | 7220 | 0.07 | Why? |
Retrospective Studies | 7 | 2021 | 105322 | 0.07 | Why? |
Lung Diseases | 1 | 2018 | 2361 | 0.07 | Why? |
Male | 13 | 2021 | 367725 | 0.06 | Why? |
Aged, 80 and over | 5 | 2021 | 88759 | 0.06 | Why? |
Humans | 21 | 2021 | 930598 | 0.06 | Why? |
Triage | 1 | 2021 | 7151 | 0.06 | Why? |
Magnetic Resonance Imaging | 1 | 2019 | 6551 | 0.06 | Why? |
Dilatation, Pathologic | 1 | 2021 | 78 | 0.06 | Why? |
Female | 11 | 2021 | 380317 | 0.05 | Why? |
Predictive Value of Tests | 3 | 2020 | 9537 | 0.05 | Why? |
Pulmonary Veins | 1 | 2021 | 146 | 0.05 | Why? |
Adult | 5 | 2021 | 244371 | 0.05 | Why? |
X-Rays | 1 | 2020 | 492 | 0.04 | Why? |
Asbestos | 1 | 2017 | 45 | 0.04 | Why? |
Pneumonia, Viral | 6 | 2020 | 243684 | 0.04 | Why? |
Software | 2 | 2020 | 2501 | 0.04 | Why? |
Betacoronavirus | 6 | 2020 | 204454 | 0.04 | Why? |
Multidetector Computed Tomography | 1 | 2021 | 307 | 0.04 | Why? |
Coronavirus Infections | 6 | 2020 | 253789 | 0.04 | Why? |
Hypertension | 1 | 2019 | 8895 | 0.04 | Why? |
Lymphoma, Non-Hodgkin | 1 | 2020 | 403 | 0.04 | Why? |
Hydroxychloroquine | 1 | 2020 | 12447 | 0.04 | Why? |
Diabetes Mellitus | 1 | 2019 | 8207 | 0.04 | Why? |
Biomarkers | 1 | 2019 | 23361 | 0.04 | Why? |
Esophageal Neoplasms | 1 | 2020 | 357 | 0.04 | Why? |
Lymphadenopathy | 1 | 2021 | 444 | 0.03 | Why? |
Pleural Effusion | 1 | 2021 | 680 | 0.03 | Why? |
Lymph Nodes | 1 | 2021 | 1060 | 0.03 | Why? |
Pulmonary Artery | 1 | 2021 | 803 | 0.03 | Why? |
Radiologists | 1 | 2020 | 873 | 0.03 | Why? |
Cardiovascular Diseases | 1 | 2019 | 11497 | 0.03 | Why? |
Diagnosis, Computer-Assisted | 1 | 2018 | 436 | 0.03 | Why? |
Risk Factors | 2 | 2019 | 71621 | 0.03 | Why? |
Infection Control | 1 | 2021 | 23131 | 0.03 | Why? |
Neoplasms | 1 | 2020 | 17251 | 0.03 | Why? |
Carcinoma, Squamous Cell | 1 | 2020 | 902 | 0.03 | Why? |
Image Interpretation, Computer-Assisted | 1 | 2018 | 665 | 0.03 | Why? |
Fatal Outcome | 1 | 2020 | 3438 | 0.03 | Why? |
Diagnostic Tests, Routine | 1 | 2020 | 2643 | 0.02 | Why? |
Antibodies, Viral | 1 | 2020 | 51949 | 0.02 | Why? |
ROC Curve | 1 | 2020 | 6024 | 0.02 | Why? |
Point-of-Care Testing | 1 | 2020 | 2782 | 0.02 | Why? |
Young Adult | 1 | 2018 | 93724 | 0.02 | Why? |
Drug Therapy, Combination | 1 | 2020 | 7268 | 0.02 | Why? |
Pandemics | 7 | 2020 | 389249 | 0.02 | Why? |
Prognosis | 2 | 2020 | 32490 | 0.02 | Why? |
Emergency Service, Hospital | 2 | 2020 | 14232 | 0.02 | Why? |
Prospective Studies | 2 | 2020 | 43301 | 0.02 | Why? |
Patient Admission | 1 | 2020 | 5250 | 0.02 | Why? |
Treatment Outcome | 2 | 2020 | 51732 | 0.02 | Why? |
Asymptomatic Infections | 1 | 2020 | 7218 | 0.01 | Why? |
Sensitivity and Specificity | 1 | 2020 | 22971 | 0.01 | Why? |
Disease Progression | 1 | 2018 | 13580 | 0.01 | Why? |
Occupational Exposure | 1 | 2017 | 4742 | 0.01 | Why? |
Anti-Bacterial Agents | 1 | 2020 | 10083 | 0.01 | Why? |
Prevalence | 1 | 2020 | 25773 | 0.01 | Why? |
Cohort Studies | 1 | 2020 | 36005 | 0.01 | Why? |
Incidence | 1 | 2017 | 25622 | 0.01 | Why? |
Risk Assessment | 1 | 2018 | 25439 | 0.01 | Why? |
Intensive Care Units | 1 | 2020 | 29594 | 0.01 | Why? |
Disease Outbreaks | 1 | 2020 | 27595 | 0.01 | Why? |
Severity of Illness Index | 1 | 2019 | 48226 | 0.01 | Why? |
Hospitalization | 1 | 2020 | 54280 | 0.01 | Why? |
Antiviral Agents | 1 | 2020 | 41703 | 0.01 | Why? |